TrialEuropean journal of pediatrics2020

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.

Mónica Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.